Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Recruiting · NCT04665206 · Registry updated 2026-04-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors | Neoplasms by Histologic Type, adenoma, epithelial neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-04-02 | NCT04665206 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vivace Therapeutics, Inc | 2 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Linear Clinical Research | Nedlands | Australia | 23 |
| M Health Fairview University of Minnesota Medical Center | Minneapolis | United States | 10 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Monash Health | Clayton | Australia | 74 |
| NEXT Oncology | San Antonio | United States | 70 |
| Peter MacCullum Cancer Centre | Melbourne | Australia | 1 |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | United States | 22 |
| University of Chicago Medical Center | Chicago | United States | 152 |
| Virginia Cancer Specialists, PC | Arlington | United States | 5 |